SCHEMBL18376806

SCHEMBL18376806

CNS(=O)(=O)c1ccc(-c2cccc3cnc(Nc4cnc(N5CCN(C)CC5)nc4)nc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.51
▸ BRD4 O60885 4/20 0.51
▸ EGFR P00533 1/20 0.44
▸ MAPK10 P53779 5/20 0.43
▸ JUN P05412 3/20 0.43
▸ MAPK8 P45983 3/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ CTSC P53634 1/20 0.43
▸ FGFR4 P22455 2/20 0.42
▸ TTK P33981 1/20 0.42
▸ AURKA O14965 1/20 0.42
▸ CDK4 P11802 1/20 0.42
▸ FLT3 P36888 1/20 0.41
▸ PTK2 Q05397 3/20 0.41
▸ JAK1 P23458 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ FGFR2 P21802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29371298 1.00 JAK2 (0.51) JAK2BRD4EGFRMAPK10JUN
SCHEMBL18377076 0.89 JAK2 (0.65) JAK2BRD4EGFRFGFR1FGFR4
SCHEMBL29371808 0.87 JAK2 (0.58) JAK2BRD4EGFRFGFR1KDR
SCHEMBL18377030 0.87 JAK2 (0.58) JAK2BRD4EGFRFGFR1KDR
SCHEMBL18376838 0.84 BRD4 (0.49) JAK2BRD4EGFRMAPK10JUN
SCHEMBL29370835 0.84 BRD4 (0.49) JAK2BRD4EGFRMAPK10JUN
SCHEMBL18376798 0.83 JAK2 (0.55) JAK2BRD4FGFR1FGFR4AURKA
SCHEMBL18376805 0.83 MAPK10 (0.57) JAK2BRD4EGFRMAPK10JUN
SCHEMBL18376655 0.79 JAK2 (0.67) JAK2BRD4FGFR1FGFR4AURKA
SCHEMBL18376841 0.79 MAPK10 (0.53) JAK2BRD4EGFRMAPK10JUN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback